AB 389
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Plasma Protein Therapeutics Association | Lobbied on it | Plasma Protein Therapeutics Association named AB 389 in 7 lobbying reports. | 7 reports |
| CSL Behring | Lobbied on it | CSL Behring named AB 389 in 6 lobbying reports. | 6 reports |
| California Medical Association and Affiliates | Lobbied on it | California Medical Association and Affiliates named AB 389 in 6 lobbying reports. | 6 reports |
| Hemophilia Council of California | Lobbied on it | Hemophilia Council of California named AB 389 in 6 lobbying reports. | 6 reports |
| Herndon Healthcare, Inc. dba Herndon Pharmacy | Lobbied on it | Herndon Healthcare, Inc. dba Herndon Pharmacy named AB 389 in 6 lobbying reports. | 6 reports |
| Grifols Shared Services North America, Inc. | Lobbied on it | Grifols Shared Services North America, Inc. named AB 389 in 4 lobbying reports. | 4 reports |
| Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. | Lobbied on it | Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. named AB 389 in 3 lobbying reports. | 3 reports |
| Baxter Healthcare Corporation | Lobbied on it | Baxter Healthcare Corporation named AB 389 in 2 lobbying reports. | 2 reports |
| Bleeding disorders. | Source records | AB 389 has an explicit source reference to Bleeding disorders.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…